Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

EDAP TMS S.A. - American Depositary Shares, each representing One Ordinary Share (NQ:EDAP)

2.390 -0.020 (-0.83%)
Streaming Delayed Price Updated: 12:27 PM EDT, Sep 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about EDAP TMS S.A. - American Depositary Shares, each representing One Ordinary Share

< Previous 1 2 3 Next >
12 Health Care Stocks Moving In Wednesday's After-Market Session
 
Via Benzinga
Earnings Scheduled For August 28, 2025
 
Via Benzinga
What's Next: Edap TMS's Earnings Preview
 
Via Benzinga
Earnings Preview For Edap TMS
 
Via Benzinga
A Glimpse of Edap TMS's Earnings Potential
 
Via Benzinga
Earnings Outlook For Edap TMS
 
Via Benzinga
Recap: Edap TMS Q3 Earnings
 
Via Benzinga
Earnings Scheduled For May 15, 2025
 
Via Benzinga
Edap TMS's Earnings Outlook
 
Via Benzinga
This Eastman Chemical Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday
 
Via Benzinga
This Dow Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday
 
Via Benzinga
Topics Stocks
12 Health Care Stocks Moving In Thursday's After-Market Session
 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
 
Via Benzinga
Recap: Edap TMS Q1 Earnings
 
Via Benzinga
Edap TMS Earnings Preview
 
Via Benzinga
Edap TMS's Earnings: A Preview
 
Via Benzinga
Earnings Scheduled For March 27, 2025
 
Via Benzinga
EDAP Stock Earnings: Edap TMS Misses EPS, Beats Revenue for Q1 2024
EDAP stock results show that Edap TMS missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024. 
Via InvestorPlace
EDAP Stock Earnings: Edap TMS Misses EPS, Beats Revenue for Q4 2023
EDAP stock results show that Edap TMS missed analyst estimates for earnings per share but beat on revenue for the fourth quarter of 2023. 
Via InvestorPlace
Earnings Scheduled For March 27, 2024
Companies Reporting Before The Bell • Local Bounti (NYSE:LOCL) is projected to report quarterly loss at $2.41 per share on revenue of $8.70 million. 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
 
Via Benzinga
7 Biotech Stocks Sitting in the Sweet Spot
Biotech stocks have the potential for massive profits if their companies are successful in developing drugs that are safe and marketable. 
Via InvestorPlace
IDEXX Laboratories Stock Clears Technical Benchmark, Hitting 80-Plus RS Rating
IDEXX Laboratories sees its Relative Strength Rating reach the 80-plus level. 
Via Investor's Business Daily
Intuit To $490? Here Are 5 Other Price Target Changes For Friday
Barclays cut Intuit Inc. (NASDAQ: INTU) price target from $502 to $490. . Barclays analyst Raimo Lenschow maintained an Overweight rating on the stock. Intuit shares fell 3% to close at $381.88 on... 
Via Benzinga
Earnings Outlook For Edap TMS
Edap TMS (NASDAQ:EDAP) is set to give its latest quarterly earnings report on Wednesday, 2022-11-16. Here's what investors need to know before the announcement. Analysts estimate that Edap TMS will... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers Monopar Therapeutics (NASDAQ:MNPR) shares increased by 53.0% to $4.09 during Wednesday's pre-market session. The company's market cap stands at $52.0 million. 
Via Benzinga
Earnings Scheduled For November 16, 2022
Companies Reporting Before The Bell • Golden Ocean Group (NASDAQ:GOGL) is estimated to report earnings for its third quarter. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 1, 2022
Upgrades 
Via Benzinga
Why NanoVibronix Shares Surged Over 25%; Here Are 82 Biggest Movers From Friday
Gainers Golden Sun Education Group Limited (NASDAQ: GSUN) shares surged 92.1% to settle at $52.89 on Friday. 
Via Benzinga
Why Shares Of Oil & Gas Companies Are Trading Lower, Here Are 62 Stocks Moving In Friday's Mid-Day Session
Gainers Kiromic BioPharma, Inc. (NASDAQ: KRBP) shares jumped 87% to $0.4791. Kiromic BioPharma, said on Sept. 15, that the company received letter from the Nasdaq that co. has been granted 180-day... 
Via Benzinga
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.